These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10692743)

  • 1. Naratriptan.
    Salonen R
    Int J Clin Pract; 1999; 53(7):552-6. PubMed ID: 10692743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability and efficacy of naratriptan tablets with long-term treatment (6 months). Naratriptan Long-term Study Group.
    Bomhof MA; Heywood J; Pradalier A; Enahoro H; Winter P; Hassani H
    Cephalalgia; 1998 Jan; 18(1):33-7. PubMed ID: 9601622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group.
    Havanka H; Dahlöf C; Pop PH; Diener HC; Winter P; Whitehouse H; Hassani H
    Clin Ther; 2000 Aug; 22(8):970-80. PubMed ID: 10972633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability and efficacy of naratriptan tablets in the acute treatment of migraine attacks for 1 year. Naratriptan Long-Term Study Group.
    Heywood J; Bomhof MA; Pradalier A; Thaventhiran L; Winter P; Hassani H
    Cephalalgia; 2000 Jun; 20(5):470-4. PubMed ID: 11037743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacy-clinic medication of the month. Naratriptan (naramig)].
    Scheen AJ
    Rev Med Liege; 1999 Mar; 54(3):189-91. PubMed ID: 10321110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.
    Ashcroft DM; Millson D
    Pharmacoepidemiol Drug Saf; 2004 Feb; 13(2):73-82. PubMed ID: 14998068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.
    Bomhof M; Paz J; Legg N; Allen C; Vandormael K; Patel K
    Eur Neurol; 1999; 42(3):173-9. PubMed ID: 10529545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine.
    Brandes JL; Smith T; Diamond M; Ames MH
    Headache; 2007 Jun; 47(6):886-94. PubMed ID: 17578540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan.
    Stark S; Spierings EL; McNeal S; Putnam GP; Bolden-Watson CP; O'Quinn S
    Headache; 2000; 40(7):513-20. PubMed ID: 10940089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naratriptan: an alternative for migraine.
    Dulli DA
    Ann Pharmacother; 1999 Jun; 33(6):704-11. PubMed ID: 10410185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low migraine headache recurrence with naratriptan: clinical parameters related to recurrence.
    Sheftell F; O'Quinn S; Watson C; Pait D; Winter P
    Headache; 2000 Feb; 40(2):103-10. PubMed ID: 10759909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience.
    Welch KM
    Cephalalgia; 2001; 21 Suppl 1():25-8. PubMed ID: 11678818
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral almotriptan in the treatment of migraine: safety and tolerability.
    Dodick DW
    Headache; 2001 May; 41(5):449-55. PubMed ID: 11380642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group.
    Klassen A; Elkind A; Asgharnejad M; Webster C; Laurenza A
    Headache; 1997; 37(10):640-5. PubMed ID: 9439085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group.
    Mathew NT; Asgharnejad M; Peykamian M; Laurenza A
    Neurology; 1997 Dec; 49(6):1485-90. PubMed ID: 9409334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of naratriptan on myocardial blood flow and coronary vasodilator reserve in migraineurs.
    Gnecchi-Ruscone T; Bernard X; Pierre P; Anderson D; Legg N; Enahoro H; Winter PD; Crisp A; Melin JA; Camici PG
    Neurology; 2000 Jul; 55(1):95-9. PubMed ID: 10891912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials.
    Bussone G; D'Amico D; McCarroll KA; Gerth W; Lines CR
    Eur Neurol; 2002; 48(3):172-7. PubMed ID: 12373035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan: pharmacological basis and clinical results.
    Dahlöf CG
    Curr Med Res Opin; 2001; 17 Suppl 1():s35-45. PubMed ID: 12463276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine.
    Garcia-Ramos G; MacGregor EA; Hilliard B; Bordini CA; Leston J; Hettiarachchi J
    Cephalalgia; 2003 Nov; 23(9):869-76. PubMed ID: 14616928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Improved pharmacokinetics. Fast tryptan with sustained response].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():106-7. PubMed ID: 14579498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.